A) The lack of potential applications. B) The ease of obtaining stem cells from adults. C) The use of embryonic stem cells. D) The uncontroversial ethical implications.
A) Ethical guidelines and regulations. B) Funding from private corporations only. C) Ignoring public opinions and concerns. D) Speed of research progress above all else.
A) To avoid sharing scientific breakthroughs. B) To address regulatory disparities and ensure ethical standards. C) To eliminate competition among research institutions. D) To hinder progress in the field.
A) Excluding patient advocates from the research process. B) Promoting unregulated stem cell experimentation. C) Developing international policy guidance on stem cell research. D) Creating financial barriers to stem cell research.
A) Speed up the aging process in patients. B) Create artificial intelligence using stem cells. C) Repair, replace, and regenerate damaged cells or tissues. D) Replace traditional medicine for all illnesses.
A) To prioritize scientific progress over societal implications. B) To ignore public opinions and concerns. C) To only focus on economic factors. D) To address diverse views on ethics, religious beliefs, and values that impact policy decisions.
A) Advocating for unrestricted research with no ethical oversight. B) Opposing all forms of medical research involving stem cells. C) Serving as decision-makers for all stem cell research projects. D) Providing expertise on ethical implications and considerations.
A) Totipotent cells can develop into any type of cell, including embryonic tissues, while pluripotent cells can develop into almost any type of cell. B) Pluripotent cells can only divide a limited number of times. C) There is no difference between the two types of stem cells. D) Pluripotent cells are more versatile than totipotent cells. |